Brought to you by

March 31, 2014 Issue:

Recent Health Care M&A Deals

Medical Devices







Sense4Baby, Inc.


North Coast Medical, Inc.

ActivaTek, Inc.





Vertical Pharmaceuticals, LLC

Rights to Divigel


Concordia Healthcare

Rights to Donnatal

$265.3 million




Albany Molecular
Research Inc.

Cedarburg Hauser
Pharmaceuticals, Inc.



Technology Deal of the Week
Concordia Healthcare Corp. (TSX: CXR; OTCQA: CHEHF) has acquired Donnatal®, an adjunctive therapy in the treatment of irritable bowel syndrome (IBS) and acute enterocolitis. IBS affects up to 45 million people in the United States, according to the International Foundation for Functional Gastrointestinal Disorders, and is second only to the common cold as a cause of workplace absenteeism. Concordia will pay $200 million in cash and an aggregate of 4,605,833 common shares, for an approximate total of $265.3 million, to privately held Revive Pharmaceuticals. Torreya Partners and GMP Securities are acting as financial advisors to Concordia. Lazard Middle Market is acting as Revive’s financial advisor……Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Charted Territory
The first quarter of 2014 started out with a surge, but is ending with a snooze. Deal making activity largely dried up at the end of March, so it doesn’t feel premature to publish the preliminary list of Biggest Deals of Q1:2014. Although Pharmaceuticals or Biotechnology are the sectors that typically dominate the list of big spenders, there was a good mix of Long-Term Care, Medical Devices and even a Laboratories, MRI & Dialysis sector deal. Look for the Health Care M&A Report on all the first quarter deals, coming soon.   
Top 10 Health Care M&A Transactions in Q1:14






Actavis Inc.

Forest Laboratories

$25 billion


The Carlyle Group

Diagnostics, Inc.

$4.15 billion


Forest Laboratories

Aptalis Pharma

2.9 billion


Brookdale Senior Living

Emeritus Corporation

$2.8 billion


Smith & Nephew plc

ArthroCare Corp

$1.7 billion



Cadence Pharmaceuticals

$1.3 billion


GE Healthcare

Assets from Thermo Fisher

$1.06 billion


NorthStar Realty Finance

80 senior care facilities

$1.05 billion



Medpace, Inc.

$915 million


Montagu Private Equity

Rexam’s healthcare units

$805 million

Source: The Health Care M&A News, March 2014
Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today
Services Deal of the Week
The nonprofit Lower Cape Fear Hospice & LifeCareCenter, based in Wilmington, North Carolina, has taken on Mercy Care, a nonprofit hospice in Myrtle Beach, South Carolina, effective April 1. Mercy Care will retain its name and brand, while several administrative and operational functions will by combined through Lower Cape Fear’s home office. Lower Cape Fear Hospice and LifeCareCenter cares for more than 600 hospice and palliative care patients in surrounding counties, while Mercy Care serves about 130 hospice and palliative care patients in its area……..Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
In the Pipeline
Investing in medical marijuana isn’t just about greenhouses and rolling paper. Last week, Smart Ventures Inc. announced it had hired a fund manager to launch its initial private placement capital raise of $100 million, targeting private and public medical marijuana companies, including retail outlets, edibles, vaporizer oil and pens, cannabis tracking technology, payment processing, vending machines, production equipment, real estate related to cannabis markets and other related services. Cannabis Funding Group, Inc. is a Colorado corporation wholly owned by Smart Ventures…….Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
BioTrinity 2014 – European Biopartnering and Investment Conference, May 12-14, London, UK
Join 1000+ delegates from 30 countries at Europe’s Premier Biopartnering and Investment Conference: BioTrinity 2014. BioTrinity 2014 brings together R&D companies and Global Pharma organisations with more biomedical investors than any other European partnering conference.

To find out more about BioTrinity, or to register, please visit:
NEW – The Health Care Services Acquisition Report, 20th Edition – Preorder Offer Expires Today!
Deals have been made. The 2014 Health Care Services Acquisition Report contains private deals in this market that are frequently too small to make into financial press. Take advantage of our limited 2-for-1 offer – Preorder The 2014 Health Services Care Acquisition Report by March 31st and receive The 2013 Health Care Services Acquisition Report FREE ($595 value)! Now that’s a deal! Go to or call 800-248-1668 to preorder today.
Around the Web in Health Care M&A…Click here to see more
Webcast Calendar…Click here to see more
Upcoming Conference Partnerships… Click here to see more